Hypoxia-targeted gold nanorods for cancer photothermal therapy

Tumor hypoxia is a well-recognized driver of resistance to traditional cancer therapies such as chemotherapy and radiation therapy. We describe development of a new nanoconstruct composed of gold nanorods (GNRs) conjugated to carbonic anhydrase IX (CAIX) antibody that specifically binds to CAIX, a b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuan, Bian, Xiaomei, Aliru, Maureen, Deorukhkar, Amit A., Ekpenyong, Oscar, Liang, Su, John, Jyothy, Ma, Jing, Gao, Xiuqing, Schwartz, Jon, Singh, Pankaj, Ye, Yuanqing, Krishnan, Sunil, Xie, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995181/
https://www.ncbi.nlm.nih.gov/pubmed/29899876
http://dx.doi.org/10.18632/oncotarget.25492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995181/
https://www.ncbi.nlm.nih.gov/pubmed/29899876
http://dx.doi.org/10.18632/oncotarget.25492

Ejemplares similares